Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01910727 · ClinicalTrials.gov registry record · NA

Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth

A NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.

Completed
Registry status
NA
Development phase
506
Enrollment target

NCT01910727: Completed NA study, sponsored by Johns Hopkins Bloomberg School of Public Health.

NCT01910727 is a NA study that has completed, run by Johns Hopkins Bloomberg School of Public Health. The registered enrollment target is 506 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01910727, a NA study, has completed, sponsored by Johns Hopkins Bloomberg School of Public Health.

COMPLETED
Registry status
NA
Development phase
506 participants
Enrollment target

Study Summary

The objective of the Together on Diabetes study is to test the efficacy of a pilot intervention to improve the prevention and management of type 2 diabetes among American Indian youth. The primary aim of this study is to determine the impact of the Together on Diabetes pilot intervention on youth diabetes risk behaviors, including: * Improvement in youth dietary intake, with a specific focus on reducing the percent of total calories from fat. * Improvement in youth physical activity, with a specific focus on increasing the number of minutes of physical activity each week. An additional primary aim of the study is to determine the feasibility and acceptability of the pilot intervention and evaluation, including program adherence and program satisfaction. The secondary aim of this study is to determine the feasibility of collecting data to determine program impact on a number of physiological measures.

Interventions

  • BEHAVIORAL Together on Diabetes-Hopkins

Trial Details

FieldValue
Enrollment Target 506 participants
Start Date 2011-12
Est. Completion 2015-07
Phase NA

What the finished NCT01910727 record still lists

NCT01910727 is an interventional study that assigns participants to a tested intervention. The registered 506 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (64% lower).

The record links to 0 conditions, and to 1 intervention - of which Together on Diabetes-Hopkins is the first listed.

NCT01910727 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01910727 about?

NCT01910727 is a clinical study titled "Together on Diabetes Study: Evaluation of a Pilot Diabetes Prevention and Management Program for American Indian Youth". The objective of the Together on Diabetes study is to test the efficacy of a pilot intervention to improve the prevention and management of type 2 diabetes among American Indian youth. The primary aim of this study is to determine the impact of the Together on Diabetes pilot intervention on youth d...

What is the current status of trial NCT01910727?

This trial is currently completed. It is a NA study. The enrollment target is 506 participants. The study started on 2011-12. Estimated completion is 2015-07.

What interventions are being tested in trial NCT01910727?

The interventions under investigation include: Together on Diabetes-Hopkins (BEHAVIORAL).

Who is sponsoring clinical trial NCT01910727?

This trial is sponsored by Johns Hopkins Bloomberg School of Public Health, which has 187 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01910727's enrollment target sits among peer trials

506 193rd of 2000 higher than 1,808 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05069428 · 506 participants · Phase 4

    Delirium Reduction With Ramelteon

  • NCT05797168 · 506 participants · Phase 1

    Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors

  • NCT06164717 · 507 participants · NA

    Behavioral and Neural Characteristics of Adaptive Speech Motor Control

  • NCT02115295 · 508 participants · Phase 2

    Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01910727, the US trial registry maintained by the National Library of Medicine. NCT01910727 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.